Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature.
about
Liver transplantation for cholangiocarcinoma: Current status and new insightsManagement and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration.Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells.Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies.Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resectionUpdate on the management of cholangiocarcinoma.Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.Delayed ethanol elimination and enhanced susceptibility to ethanol-induced hepatosteatosis after liver resection.Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinomaReview article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinomaOverexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma.Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma.Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinomaAberrant DNA methylation profile in cholangiocarcinoma.Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy.Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma.Advances in the management of biliary tract cancersImaging bile duct tumors: pathologic concepts, classification, and early tumor detection.Surgical treatment of intrahepatic cholangiocarcinoma in the USA.Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review.Bilateral metallic stenting in malignant hilar obstruction.Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition.Significant Improvement in Outcomes of Patients with Intrahepatic Cholangiocarcinoma after Surgery.Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma.Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma.Development and Validation of a Prognostic Score for Intrahepatic Cholangiocarcinoma.Intrahepatic cholangiocarcinoma: current management and emerging therapies.Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer.Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis.Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis.Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.Is Surgical Resection Justified for Advanced Intrahepatic Cholangiocarcinoma?Prognostic analysis of radical resection for intrahepatic cholangiocarcinoma: a retrospective cohort study.[Stereotactic Radiofrequency Ablation (SRFA) of intrahepatic cholangiocellular carcinomas: a minimal invasive alternative to liver resection].
P2860
Q26783361-B9ABC893-06E1-453F-8FC1-25481E05F084Q30279208-D400E991-B195-479F-978B-F15BC4366CB9Q30359582-86D133F9-77B0-4069-8974-D11F92FCE6DAQ33597837-3E63CD6A-C9EF-43C9-B76B-29129BC5A712Q33679691-B574D0BD-ED93-4F6A-9268-7690DEAF0343Q34024528-EC4C7EFF-3A62-4A39-9AE6-E9FF1B72528EQ34153255-ADA639BA-16E9-4026-9FCC-1B4EE0D13295Q34631650-8854113D-CB41-407C-898B-6517110B987FQ34779140-D381572B-22F8-4764-BD10-4A7E3DD0C3D5Q35108386-F1FF5C0A-5936-4ACC-B516-7325773270F4Q35607681-06771B5E-A207-4516-A4E2-26635EF0F689Q35674607-9CD97AEB-B443-420D-8E6E-2ADD68C66678Q35934826-4E0482F8-94E9-4BFF-9648-63154F33E821Q36064847-2228BE71-34CE-4213-A033-6A1B44D45F6AQ36520529-73EC92B9-44D8-4C77-912B-6E0440CEF189Q36622089-2E13464F-2956-4C15-A09E-50A4658F4567Q36656633-072FD860-CDB3-412F-8EA6-5EBD19EC9EC7Q36718761-21E61718-D344-4D8E-B86A-DD4EC704A309Q37063387-8F6C7040-2C8F-491D-972D-CBC06952FB9CQ37878880-1D9D3494-DAAF-4FEA-9DD8-D0B22ABD54E6Q37911430-2C973DAC-A907-44A1-A761-C9E526139078Q38076736-CA60846D-4EE6-45F4-8D19-E409540857D0Q38082318-67EEA434-49F9-4B8D-B187-F972D5D9A7D0Q38127390-9E9C0B21-4E26-4609-AEA9-F61D99433F66Q38245994-3AAF3CA7-4CE9-4B6F-9F88-DAAEAA29352DQ38258604-84DA9951-5D20-44D2-AAE2-1CE5C24AFCCBQ38261029-FD28651F-834D-4C2A-BEA9-39E0887EB01BQ38383198-406D24CA-8ECC-4FBD-AA7F-F9121F6730D4Q38851999-914631AC-0560-4D6E-9169-3AF8AC3EAA4CQ38890459-9AE69824-BA3B-4705-AC68-25DCA6E963B3Q38900780-EFABD615-A6E6-4D78-A262-2C47DF198250Q38905922-3DBBAD3B-2B2E-46EB-8B53-52A90B5447DEQ39186928-5D736152-8478-4EC1-82EE-13D2CC038194Q39717600-88B5E5FA-1EE1-4896-A2EC-A77B9C23776DQ40162221-E9316E8F-EDC4-4EEC-8B0F-8604E103992EQ41026801-4E622C10-5A09-40DA-9C54-75C5A1E05240Q41091924-44D744C1-92A9-4F83-8DBD-A926B69F0108Q41544531-AEFE2D4A-9871-497E-9C43-54CFAF64307CQ43170177-89547006-6F45-4BE5-9383-9654C026996DQ44221853-FF2899D4-3321-4FC9-8F38-7D1A4E2CBF15
P2860
Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence-based approach to cho ...... iew of the current literature.
@en
Evidence-based approach to cho ...... iew of the current literature.
@nl
type
label
Evidence-based approach to cho ...... iew of the current literature.
@en
Evidence-based approach to cho ...... iew of the current literature.
@nl
prefLabel
Evidence-based approach to cho ...... iew of the current literature.
@en
Evidence-based approach to cho ...... iew of the current literature.
@nl
P2093
P1476
Evidence-based approach to cho ...... view of the current literature
@en
P2093
Alhawsawi Abdulelah
Ian Alwayn
Mark Walsh
Michele Molinari
Murad Aljiffry
P304
P356
10.1016/J.JAMCOLLSURG.2008.09.007
P577
2008-10-31T00:00:00Z